Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.
To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link
The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:
- Type of manufacturing
- Custom manufacturing
- Large-scale manufacturing
- Type of Oligonucleotides manufactured
- Antisense Oligonucleotides
- miRNAs
- shRNAs
- siRNAs
- Other Oligonucleotides
- Scale of operation
- Clinical
- Commercial
- Purpose of production
- In-house
- Outsourced
- Target therapeutic area
- Autoimmune Disorders
- Cardiovascular Disorders
- Genetic Disorders
- Infectious Diseases
- Metabolic Disorders
- Neuromuscular Disorders
- Oncological Disorders
- Ophthalmic Disorders
- Other Therapeutic Areas
- Size of manufacturer
- Small
- Mid-sized
- Large
- Key Geographical Region
- North America
- Europe
- Asia-Pacific and Rest of the World
The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 report features the following companies, which we identified to be key players in this domain:
- Agilent Technologies
- Ajinomoto Bio-Pharma Services
- BioSpring
- CordenPharma
- Integrated DNA Technologies
- Kaneka Eurogentec
- LGC Biosearch Technologies
- Microsynth
- Nitto Denko Avecia
- Sigma Aldrich
- Thermo Fisher Scientific
- Trilink Biotechnologies
Table of Contents
- 1. Preface
Executive Summary
- Introduction
- Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
- Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)
- Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
- Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)
- Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
- Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)
- Partnerships and Collaborations
- Recent Expansions
- Clinical Trial Analysis
- Capacity Analysis
- Demand Analysis
- Market Sizing and Opportunity Analysis
- Swot Analysis
- Survey Analysis
- Executive Insights
- Concluding Remarks
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
